GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noxopharm Ltd (ASX:NOX) » Definitions » Float Percentage Of Total Shares Outstanding

Noxopharm (ASX:NOX) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 15, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Noxopharm Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Noxopharm's float shares is 0.00 Mil. Noxopharm's total shares outstanding is 292.24 Mil. Noxopharm's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Noxopharm's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Noxopharm's Institutional Ownership is 0.00%.

Noxopharm Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Noxopharm's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/292.24
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Noxopharm (ASX:NOX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noxopharm Ltd (ASX:NOX) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
ASX:AGN ASX:BIO ASX:RAD ASX:EZZ ASX:PAA ASX:CYP ASX:ACW ASX:1AI ASX:VBS ASX:KZA OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
NOXOF:USA
Address
60 Linksley Ave, Glenhaven, NSW, AUS, 2156
Website
https://www.noxopharm.com
Noxopharm Ltd is an Australian clinical-stage drug development company focused on treating cancer with Veyonda. It is engaged in the development in the field of both oncology and non-oncology in the pan-pacific region.

Noxopharm (ASX:NOX) Headlines

No Headlines